1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pre-Menstrual Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Analgesics (Pain Killers) 1.2.3 Oral Contraceptive Pills (OCPs) 1.2.4 Gonadotropin-Releasing Hormone (GnRH) 1.2.5 Antidepressants 1.2.6 Ovarian Suppressors 1.2.7 Diuretics 1.2.8 Benzodiazepines 1.3 Market by Application 1.3.1 Global Pre-Menstrual Syndrome Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pre-Menstrual Syndrome Market Perspective (2016-2027) 2.2 Pre-Menstrual Syndrome Growth Trends by Regions 2.2.1 Pre-Menstrual Syndrome Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pre-Menstrual Syndrome Historic Market Share by Regions (2016-2021) 2.2.3 Pre-Menstrual Syndrome Forecasted Market Size by Regions (2022-2027) 2.3 Pre-Menstrual Syndrome Industry Dynamic 2.3.1 Pre-Menstrual Syndrome Market Trends 2.3.2 Pre-Menstrual Syndrome Market Drivers 2.3.3 Pre-Menstrual Syndrome Market Challenges 2.3.4 Pre-Menstrual Syndrome Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pre-Menstrual Syndrome Players by Revenue 3.1.1 Global Top Pre-Menstrual Syndrome Players by Revenue (2016-2021) 3.1.2 Global Pre-Menstrual Syndrome Revenue Market Share by Players (2016-2021) 3.2 Global Pre-Menstrual Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pre-Menstrual Syndrome Revenue 3.4 Global Pre-Menstrual Syndrome Market Concentration Ratio 3.4.1 Global Pre-Menstrual Syndrome Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pre-Menstrual Syndrome Revenue in 2020 3.5 Pre-Menstrual Syndrome Key Players Head office and Area Served 3.6 Key Players Pre-Menstrual Syndrome Product Solution and Service 3.7 Date of Enter into Pre-Menstrual Syndrome Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pre-Menstrual Syndrome Breakdown Data by Type 4.1 Global Pre-Menstrual Syndrome Historic Market Size by Type (2016-2021) 4.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Type (2022-2027) 5 Pre-Menstrual Syndrome Breakdown Data by Application 5.1 Global Pre-Menstrual Syndrome Historic Market Size by Application (2016-2021) 5.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pre-Menstrual Syndrome Market Size (2016-2027) 6.2 North America Pre-Menstrual Syndrome Market Size by Type 6.2.1 North America Pre-Menstrual Syndrome Market Size by Type (2016-2021) 6.2.2 North America Pre-Menstrual Syndrome Market Size by Type (2022-2027) 6.2.3 North America Pre-Menstrual Syndrome Market Size by Type (2016-2027) 6.3 North America Pre-Menstrual Syndrome Market Size by Application 6.3.1 North America Pre-Menstrual Syndrome Market Size by Application (2016-2021) 6.3.2 North America Pre-Menstrual Syndrome Market Size by Application (2022-2027) 6.3.3 North America Pre-Menstrual Syndrome Market Size by Application (2016-2027) 6.4 North America Pre-Menstrual Syndrome Market Size by Country 6.4.1 North America Pre-Menstrual Syndrome Market Size by Country (2016-2021) 6.4.2 North America Pre-Menstrual Syndrome Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pre-Menstrual Syndrome Market Size (2016-2027) 7.2 Europe Pre-Menstrual Syndrome Market Size by Type 7.2.1 Europe Pre-Menstrual Syndrome Market Size by Type (2016-2021) 7.2.2 Europe Pre-Menstrual Syndrome Market Size by Type (2022-2027) 7.2.3 Europe Pre-Menstrual Syndrome Market Size by Type (2016-2027) 7.3 Europe Pre-Menstrual Syndrome Market Size by Application 7.3.1 Europe Pre-Menstrual Syndrome Market Size by Application (2016-2021) 7.3.2 Europe Pre-Menstrual Syndrome Market Size by Application (2022-2027) 7.3.3 Europe Pre-Menstrual Syndrome Market Size by Application (2016-2027) 7.4 Europe Pre-Menstrual Syndrome Market Size by Country 7.4.1 Europe Pre-Menstrual Syndrome Market Size by Country (2016-2021) 7.4.2 Europe Pre-Menstrual Syndrome Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pre-Menstrual Syndrome Market Size (2016-2027) 8.2 Asia-Pacific Pre-Menstrual Syndrome Market Size by Type 8.2.1 Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2016-2027) 8.3 Asia-Pacific Pre-Menstrual Syndrome Market Size by Application 8.3.1 Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2016-2027) 8.4 Asia-Pacific Pre-Menstrual Syndrome Market Size by Region 8.4.1 Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pre-Menstrual Syndrome Market Size (2016-2027) 9.2 Latin America Pre-Menstrual Syndrome Market Size by Type 9.2.1 Latin America Pre-Menstrual Syndrome Market Size by Type (2016-2021) 9.2.2 Latin America Pre-Menstrual Syndrome Market Size by Type (2022-2027) 9.2.3 Latin America Pre-Menstrual Syndrome Market Size by Type (2016-2027) 9.3 Latin America Pre-Menstrual Syndrome Market Size by Application 9.3.1 Latin America Pre-Menstrual Syndrome Market Size by Application (2016-2021) 9.3.2 Latin America Pre-Menstrual Syndrome Market Size by Application (2022-2027) 9.3.3 Latin America Pre-Menstrual Syndrome Market Size by Application (2016-2027) 9.4 Latin America Pre-Menstrual Syndrome Market Size by Country 9.4.1 Latin America Pre-Menstrual Syndrome Market Size by Country (2016-2021) 9.4.2 Latin America Pre-Menstrual Syndrome Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pre-Menstrual Syndrome Market Size (2016-2027) 10.2 Middle East & Africa Pre-Menstrual Syndrome Market Size by Type 10.2.1 Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2016-2027) 10.3 Middle East & Africa Pre-Menstrual Syndrome Market Size by Application 10.3.1 Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2016-2027) 10.4 Middle East & Africa Pre-Menstrual Syndrome Market Size by Country 10.4.1 Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Alva-Amco Pharmacal Cos., Inc. 11.1.1 Alva-Amco Pharmacal Cos., Inc. Company Details 11.1.2 Alva-Amco Pharmacal Cos., Inc. Business Overview 11.1.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Introduction 11.1.4 Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.1.5 Alva-Amco Pharmacal Cos., Inc. Recent Development 11.2 Bayer, Inc. 11.2.1 Bayer, Inc. Company Details 11.2.2 Bayer, Inc. Business Overview 11.2.3 Bayer, Inc. Pre-Menstrual Syndrome Introduction 11.2.4 Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.2.5 Bayer, Inc. Recent Development 11.3 Chattem, Inc. (Sanofi) 11.3.1 Chattem, Inc. (Sanofi) Company Details 11.3.2 Chattem, Inc. (Sanofi) Business Overview 11.3.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Introduction 11.3.4 Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.3.5 Chattem, Inc. (Sanofi) Recent Development 11.4 DEKK-TEC, Inc. 11.4.1 DEKK-TEC, Inc. Company Details 11.4.2 DEKK-TEC, Inc. Business Overview 11.4.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Introduction 11.4.4 DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.4.5 DEKK-TEC, Inc. Recent Development 11.5 G. R. Lane Health Products Ltd 11.5.1 G. R. Lane Health Products Ltd Company Details 11.5.2 G. R. Lane Health Products Ltd Business Overview 11.5.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Introduction 11.5.4 G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.5.5 G. R. Lane Health Products Ltd Recent Development 11.6 McNeil Consumer Healthcare 11.6.1 McNeil Consumer Healthcare Company Details 11.6.2 McNeil Consumer Healthcare Business Overview 11.6.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Introduction 11.6.4 McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.6.5 McNeil Consumer Healthcare Recent Development 11.7 MetP Pharma AG 11.7.1 MetP Pharma AG Company Details 11.7.2 MetP Pharma AG Business Overview 11.7.3 MetP Pharma AG Pre-Menstrual Syndrome Introduction 11.7.4 MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.7.5 MetP Pharma AG Recent Development 11.8 Pherin Pharmaceuticals, Inc. 11.8.1 Pherin Pharmaceuticals, Inc. Company Details 11.8.2 Pherin Pharmaceuticals, Inc. Business Overview 11.8.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Introduction 11.8.4 Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.8.5 Pherin Pharmaceuticals, Inc. Recent Development 11.9 Umecrine Mood AB 11.9.1 Umecrine Mood AB Company Details 11.9.2 Umecrine Mood AB Business Overview 11.9.3 Umecrine Mood AB Pre-Menstrual Syndrome Introduction 11.9.4 Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.9.5 Umecrine Mood AB Recent Development 11.10 Novartis AG 11.10.1 Novartis AG Company Details 11.10.2 Novartis AG Business Overview 11.10.3 Novartis AG Pre-Menstrual Syndrome Introduction 11.10.4 Novartis AG Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.10.5 Novartis AG Recent Development 11.11 GlaxoSmithKline Plc 11.11.1 GlaxoSmithKline Plc Company Details 11.11.2 GlaxoSmithKline Plc Business Overview 11.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Introduction 11.11.4 GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2016-2021) 11.11.5 GlaxoSmithKline Plc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pre-Menstrual Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Analgesics (Pain Killers) Table 3. Key Players of Oral Contraceptive Pills (OCPs) Table 4. Key Players of Gonadotropin-Releasing Hormone (GnRH) Table 5. Key Players of Antidepressants Table 6. Key Players of Ovarian Suppressors Table 7. Key Players of Diuretics Table 8. Key Players of Benzodiazepines Table 9. Global Pre-Menstrual Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Pre-Menstrual Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Pre-Menstrual Syndrome Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Pre-Menstrual Syndrome Market Share by Regions (2016-2021) Table 13. Global Pre-Menstrual Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Pre-Menstrual Syndrome Market Share by Regions (2022-2027) Table 15. Pre-Menstrual Syndrome Market Trends Table 16. Pre-Menstrual Syndrome Market Drivers Table 17. Pre-Menstrual Syndrome Market Challenges Table 18. Pre-Menstrual Syndrome Market Restraints Table 19. Global Pre-Menstrual Syndrome Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Pre-Menstrual Syndrome Market Share by Players (2016-2021) Table 21. Global Top Pre-Menstrual Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Menstrual Syndrome as of 2020) Table 22. Ranking of Global Top Pre-Menstrual Syndrome Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Pre-Menstrual Syndrome Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Pre-Menstrual Syndrome Product Solution and Service Table 26. Date of Enter into Pre-Menstrual Syndrome Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million) Table 29. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2016-2021) Table 30. Global Pre-Menstrual Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Pre-Menstrual Syndrome Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Pre-Menstrual Syndrome Revenue Market Share by Application (2016-2021) Table 34. Global Pre-Menstrual Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Pre-Menstrual Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million) Table 37. North America Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million) Table 39. North America Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Pre-Menstrual Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Pre-Menstrual Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Pre-Menstrual Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Pre-Menstrual Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Pre-Menstrual Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Pre-Menstrual Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2022-2027) & (US$ Million) Table 66. Alva-Amco Pharmacal Cos., Inc. Company Details Table 67. Alva-Amco Pharmacal Cos., Inc. Business Overview Table 68. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Product Table 69. Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 70. Alva-Amco Pharmacal Cos., Inc. Recent Development Table 71. Bayer, Inc. Company Details Table 72. Bayer, Inc. Business Overview Table 73. Bayer, Inc. Pre-Menstrual Syndrome Product Table 74. Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 75. Bayer, Inc. Recent Development Table 76. Chattem, Inc. (Sanofi) Company Details Table 77. Chattem, Inc. (Sanofi) Business Overview Table 78. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Product Table 79. Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 80. Chattem, Inc. (Sanofi) Recent Development Table 81. DEKK-TEC, Inc. Company Details Table 82. DEKK-TEC, Inc. Business Overview Table 83. DEKK-TEC, Inc. Pre-Menstrual Syndrome Product Table 84. DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 85. DEKK-TEC, Inc. Recent Development Table 86. G. R. Lane Health Products Ltd Company Details Table 87. G. R. Lane Health Products Ltd Business Overview Table 88. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Product Table 89. G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 90. G. R. Lane Health Products Ltd Recent Development Table 91. McNeil Consumer Healthcare Company Details Table 92. McNeil Consumer Healthcare Business Overview Table 93. McNeil Consumer Healthcare Pre-Menstrual Syndrome Product Table 94. McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 95. McNeil Consumer Healthcare Recent Development Table 96. MetP Pharma AG Company Details Table 97. MetP Pharma AG Business Overview Table 98. MetP Pharma AG Pre-Menstrual Syndrome Product Table 99. MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 100. MetP Pharma AG Recent Development Table 101. Pherin Pharmaceuticals, Inc. Company Details Table 102. Pherin Pharmaceuticals, Inc. Business Overview Table 103. Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 104. Pherin Pharmaceuticals, Inc. Recent Development Table 105. Umecrine Mood AB Company Details Table 106. Umecrine Mood AB Business Overview Table 107. Umecrine Mood AB Pre-Menstrual Syndrome Product Table 108. Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 109. Umecrine Mood AB Recent Development Table 110. Novartis AG Company Details Table 111. Novartis AG Business Overview Table 112. Novartis AG Pre-Menstrual Syndrome Product Table 113. Novartis AG Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 114. Novartis AG Recent Development Table 115. GlaxoSmithKline Plc Company Details Table 116. GlaxoSmithKline Plc Business Overview Table 117. GlaxoSmithKline Plc Pre-Menstrual Syndrome Product Table 118. GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million) Table 119. GlaxoSmithKline Plc Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Pre-Menstrual Syndrome Market Share by Type: 2020 VS 2027 Figure 2. Analgesics (Pain Killers) Features Figure 3. Oral Contraceptive Pills (OCPs) Features Figure 4. Gonadotropin-Releasing Hormone (GnRH) Features Figure 5. Antidepressants Features Figure 6. Ovarian Suppressors Features Figure 7. Diuretics Features Figure 8. Benzodiazepines Features Figure 9. Global Pre-Menstrual Syndrome Market Share by Application: 2020 VS 2027 Figure 10. Hospitals Case Studies Figure 11. Clinic Case Studies Figure 12. Others Case Studies Figure 13. Pre-Menstrual Syndrome Report Years Considered Figure 14. Global Pre-Menstrual Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Pre-Menstrual Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Pre-Menstrual Syndrome Market Share by Regions: 2020 VS 2027 Figure 17. Global Pre-Menstrual Syndrome Market Share by Regions (2022-2027) Figure 18. Global Pre-Menstrual Syndrome Market Share by Players in 2020 Figure 19. Global Top Pre-Menstrual Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Menstrual Syndrome as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Pre-Menstrual Syndrome Revenue in 2020 Figure 21. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2016-2021) Figure 22. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2022-2027) Figure 23. North America Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Pre-Menstrual Syndrome Market Share by Type (2016-2027) Figure 25. North America Pre-Menstrual Syndrome Market Share by Application (2016-2027) Figure 26. North America Pre-Menstrual Syndrome Market Share by Country (2016-2027) Figure 27. United States Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Pre-Menstrual Syndrome Market Share by Type (2016-2027) Figure 31. Europe Pre-Menstrual Syndrome Market Share by Application (2016-2027) Figure 32. Europe Pre-Menstrual Syndrome Market Share by Country (2016-2027) Figure 33. Germany Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Pre-Menstrual Syndrome Market Share by Type (2016-2027) Figure 41. Asia-Pacific Pre-Menstrual Syndrome Market Share by Application (2016-2027) Figure 42. Asia-Pacific Pre-Menstrual Syndrome Market Share by Region (2016-2027) Figure 43. China Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Pre-Menstrual Syndrome Market Share by Type (2016-2027) Figure 51. Latin America Pre-Menstrual Syndrome Market Share by Application (2016-2027) Figure 52. Latin America Pre-Menstrual Syndrome Market Share by Country (2016-2027) Figure 53. Mexico Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Pre-Menstrual Syndrome Market Share by Type (2016-2027) Figure 57. Middle East & Africa Pre-Menstrual Syndrome Market Share by Application (2016-2027) Figure 58. Middle East & Africa Pre-Menstrual Syndrome Market Share by Country (2016-2027) Figure 59. Turkey Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Alva-Amco Pharmacal Cos., Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 63. Bayer, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 64. Chattem, Inc. (Sanofi) Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 65. DEKK-TEC, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 66. G. R. Lane Health Products Ltd Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 67. McNeil Consumer Healthcare Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 68. MetP Pharma AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 69. Pherin Pharmaceuticals, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 70. Umecrine Mood AB Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 71. Novartis AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 72. GlaxoSmithKline Plc Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Alva-Amco Pharmacal Cos., Inc. Bayer, Inc. Chattem, Inc. (Sanofi) DEKK-TEC, Inc. G. R. Lane Health Products Ltd McNeil Consumer Healthcare MetP Pharma AG Pherin Pharmaceuticals, Inc. Umecrine Mood AB Novartis AG GlaxoSmithKline Plc